Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases

Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases

US Patent 9532987 · Granted Jan 3, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor fo2025
Treatment of cancer using combination therapies comprising GDC-6036 and GDC-00772025
Methods and compositions comprising a KRASG12C inhibitor and a PD-L1 binding ant2024
Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor fo2024
Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer2021
Combinations of AKT inhibitor compounds and vemurafenib, and methods of use2015
Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor com2015
SCDs as modifiers of the p53 pathway and methods of use2014
Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic a2013
MAP3Ks as modifiers of the p53 pathway and methods of use2012
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeut2012
Marks as modifiers of the p53 pathway and methods of use2012